Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Martinelli

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2021
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice GuidelinesA Vogel, E Martinelli, , et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2023
Updated treatment recommendation for third-line treatment in advanced colorectal cancer from the ESMO Metastatic Colorectal Cancer Living GuidelineA Cervantes, E Martinelli,
Der Urologe. Ausg. A|December 18, 2015
[Pharmacological treatment of benign prostatic hyperplasia]M Oelke, E Martinelli
FEBS Letters|December 15, 1974
Ansamycin biogenesis: incorporation of (1-13C)glucose and (1-13C)glycerate into the chromophore of rifamycin SR J White, E Martinelli
Preparative Biochemistry|January 1, 1980
A convenient preparation of tetrahydropteridines and tetrahydrofolate analogs. Synthesis of tetrahydro-3',5'-dichloromethotrexateJ E Martinelli, M Chaykovsky
Clinical Endocrinology|July 1, 1994
Relation between growth hormone and cortisol spontaneous secretion in childrenC E Martinelli, A C Moreira
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2024
Updated treatment recommendations for third and further lines of treatment in advanced colorectal cancer: from the ESMO Metastatic Colorectal Cancer Living GuidelineL Candia, A Cervantes, E Martinelli, et al.
ESMO Open|March 2, 2023
Lenvatinib plus pembrolizumab a new effective combination of targeted agentsJ A Perez-Fidalgo, E Martinelli
Il Farmaco; Edizione Scientifica|June 1, 1975
Diftalone. Synthesis and chemical behaviour of its metabolic productsE Bellasio, E Martinelli, G Nathansohn
ESMO Open|December 22, 2022
Targeting KRAS<sup>G12C</sup> in colorectal cancer: the beginning of a new eraD Ciardiello, B A Maiorano, E Martinelli
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2021
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice GuidelinesA Vogel, E Martinelli, , et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2023
Updated treatment recommendation for third-line treatment in advanced colorectal cancer from the ESMO Metastatic Colorectal Cancer Living GuidelineA Cervantes, E Martinelli,
Der Urologe. Ausg. A|December 18, 2015
[Pharmacological treatment of benign prostatic hyperplasia]M Oelke, E Martinelli
FEBS Letters|December 15, 1974
Ansamycin biogenesis: incorporation of (1-13C)glucose and (1-13C)glycerate into the chromophore of rifamycin SR J White, E Martinelli
Preparative Biochemistry|January 1, 1980
A convenient preparation of tetrahydropteridines and tetrahydrofolate analogs. Synthesis of tetrahydro-3',5'-dichloromethotrexateJ E Martinelli, M Chaykovsky
Clinical Endocrinology|July 1, 1994
Relation between growth hormone and cortisol spontaneous secretion in childrenC E Martinelli, A C Moreira
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2024
Updated treatment recommendations for third and further lines of treatment in advanced colorectal cancer: from the ESMO Metastatic Colorectal Cancer Living GuidelineL Candia, A Cervantes, E Martinelli, et al.
ESMO Open|March 2, 2023
Lenvatinib plus pembrolizumab a new effective combination of targeted agentsJ A Perez-Fidalgo, E Martinelli
Il Farmaco; Edizione Scientifica|June 1, 1975
Diftalone. Synthesis and chemical behaviour of its metabolic productsE Bellasio, E Martinelli, G Nathansohn
ESMO Open|December 22, 2022
Targeting KRAS<sup>G12C</sup> in colorectal cancer: the beginning of a new eraD Ciardiello, B A Maiorano, E Martinelli
Pageof 20